| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/10/2013 | US20130011410 Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011403 Klebsiella antigens |
| 01/10/2013 | US20130011400 Methods For Inducing Autolysis In Infectious Bacteria |
| 01/10/2013 | US20130011398 Serpin Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011394 Complexes comprising mhc class i fusion polypeptides and antigen-specific antibodies and methods of use |
| 01/10/2013 | US20130011388 Intravenous immunoglobulin composition |
| 01/10/2013 | US20130011386 Active protease-resistant antibody fc mutants |
| 01/10/2013 | US20130011375 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 01/10/2013 | US20130011369 Method for Prevention and Treatment of Salmonella Infection |
| 01/10/2013 | US20130011366 Therapeutic Agent for infections, and treatment method using the same |
| 01/10/2013 | US20130011363 Cationic betaine precursors to zwitterionic betaines having controlled biological properties |
| 01/10/2013 | US20130011351 Antimycotic pharmaceutical composition |
| 01/10/2013 | US20130011344 Use of iminocyclitols as inhibitors of bacterial adherence to epithelial cells |
| 01/10/2013 | US20130011342 Surfactant-free, water-free formable composition and breakable foams and their uses |
| 01/10/2013 | CA2843854A1 Herpes virus vaccine and methods of use |
| 01/10/2013 | CA2841376A1 N-terminal deleted gp120 immunogens |
| 01/10/2013 | CA2841047A1 Immunogenic compositions and uses thereof |
| 01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
| 01/10/2013 | CA2839678A1 Process for the preparation of a pharmaceutically effective extract from arthrospira spec. |
| 01/10/2013 | CA2838659A1 Darunavir combination formulations |
| 01/10/2013 | CA2837539A1 Darunavir formulations |
| 01/09/2013 | EP2543664A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/09/2013 | EP2543387A1 Mucosal vaccine |
| 01/09/2013 | EP2543383A1 Macrocyclic compounds and methods of treatment |
| 01/09/2013 | EP2543381A1 Immunoglobulin a secretion promoter |
| 01/09/2013 | EP2543370A1 Compositions and Methods for Treating Herpes Simplex Virus |
| 01/09/2013 | EP2542892A2 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/09/2013 | EP2542577A1 Improved therapeutic antibodies against flagellated pseudomonas aeruginosa |
| 01/09/2013 | EP2542570A1 Target of egr1 (toe1 ) polypeptides for inhibition of hiv |
| 01/09/2013 | EP2542566A2 Molecular clone of hiv-1 |
| 01/09/2013 | EP2542554A1 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | EP2542305A2 Enhanced anti-microbial pdt |
| 01/09/2013 | EP2542265A2 Guanidinylated aminoglycoside -lipid conjugates |
| 01/09/2013 | EP2542247A1 Nucleic acids for targeting multiple regions of the hcv genome |
| 01/09/2013 | EP2542245A1 Antimicrobial cationic stereoids and methods of use |
| 01/09/2013 | EP2542240A1 Compositions and methods for treating viral diseases |
| 01/09/2013 | EP2542238A1 Compounds for immunoproteasome inhibition |
| 01/09/2013 | EP2542221A2 Concentrated protein formulations and uses thereof |
| 01/09/2013 | EP2542059A1 Compositions comprising myristic acid and uses thereof |
| 01/09/2013 | CN102869664A Pyrazolopyrimidine kinase inhibitors |
| 01/09/2013 | CN102869661A Anti-infective compounds |
| 01/09/2013 | CN102869657A Analogues for the treatment or prevention of flavivirus infections |
| 01/09/2013 | CN102869376A Treatment of streptococcal infections |
| 01/09/2013 | CN102869367A Novel cyclic peptides |
| 01/09/2013 | CN102869365A Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders |
| 01/09/2013 | CN102864157A Immune protective antigen of haemophilus parasuis |
| 01/09/2013 | CN102864154A A group of Cathelicidins antimicrobial peptides of chicken, preparation method and application thereof |
| 01/09/2013 | CN102864152A Immunostimulation characteristic of oligonucleotide-based compound comprising modified immunostimulation dinucleotide |
| 01/09/2013 | CN102864151A Novel synthetic agonists of tlr9 |
| 01/09/2013 | CN102864150A Nucleic acid aptamer capable of recognizing HCV NS5A protein, and derivatives, screening method and application thereof |
| 01/09/2013 | CN102864130A Recombination influenza virus for high-efficiency expression HA (hemagglutinin) protein and preparation method and application thereof |
| 01/09/2013 | CN102864129A Recombinant influenza virus for efficiently expressing HA (Hemagglutinin) protein and preparation method as well as application thereof |
| 01/09/2013 | CN102864128A Recombinant influenza virus for efficiently expressing HA protein, and preparation method and application thereof |
| 01/09/2013 | CN102864127A Recombinant influenza virus for efficiently expressing HA (Hemagglutinin) protein and preparation method as well as application thereof |
| 01/09/2013 | CN102864090A Attenuated gram negative bacteria |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863528A Bovine-derived anti-staphylococcus aureus single-chain antibody, preparation method and application thereof |
| 01/09/2013 | CN102863527A Humanized hepatitis b virus resistance surface antigen gene engineering antibodies and preparation method and application thereof |
| 01/09/2013 | CN102863512A Novel antiviral compound |
| 01/09/2013 | CN102863461A (6R, 7R)-3-hydroxymethyl-7-[alpha-(N, N'-diisopropylamidino thio)-acetamido]-8-oxo-5-thia-1-azabicycle [4, 2, 0]-oct-2-ene-2-carboxylic acid |
| 01/09/2013 | CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor |
| 01/09/2013 | CN102861333A High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken |
| 01/09/2013 | CN102861330A Haemophilus influenzae type b (Hib) polysaccharide and refined tetanus toxoid coupling process |
| 01/09/2013 | CN102861329A Production method of canine parvovirus inactivated vaccine by utilizing bioreactor |
| 01/09/2013 | CN102861328A Novel foot-and-mouth disease vaccine and preparation method thereof |
| 01/09/2013 | CN102861327A Cell inactivated vaccine, egg yoke antibody and injection and freeze-dried powder containing same |
| 01/09/2013 | CN102861326A Epidemic encephalitis polysaccharide-protein conjugated vaccine and preparation method thereof |
| 01/09/2013 | CN102861325A Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 01/09/2013 | CN102861324A Biological reagent for treating carbapenems resistant acinetobacter baumannii infection |
| 01/09/2013 | CN102861319A Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/09/2013 | CN102861310A Medicine for hepatitis B |
| 01/09/2013 | CN102861294A Thirteen-ingredient liver therapy capsule |
| 01/09/2013 | CN102861256A Method for preparing flavone from bamboo leaves |
| 01/09/2013 | CN102861255A Preparation method and quality control method for medicine and preparation thereof for treating influenza |
| 01/09/2013 | CN102861253A Foot immersing medicament for treating dermatophytosis |
| 01/09/2013 | CN102861239A Powdery Chinese patent medicine externally applied to feet of patients for treating tuberculosis and lung tumor |
| 01/09/2013 | CN102861227A Traditional Chinese medicine composition for treating suppurative meningitis sequelae and preparation method of traditional Chinese medicine composition |
| 01/09/2013 | CN102861225A Radix ophiopogonis yin-nourishing and liquid engendering tablets |
| 01/09/2013 | CN102861208A Antibacterial, anti-inflammation and antiviral traditional Chinese medicine compound |
| 01/09/2013 | CN102861206A Sterilizing and disinfecting aerosol for skin mucous membrane and preparation method thereof |
| 01/09/2013 | CN102861191A Traditional Chinese medicine for treating cold |
| 01/09/2013 | CN102861189A Traditional Chinese medicine composition for treating viral encephalitis |
| 01/09/2013 | CN102861168A Astragalus mongholicus Yin-astringing tablet |
| 01/09/2013 | CN102861162A Antiviral complex traditional Chinese medicine and preparation method and application thereof |
| 01/09/2013 | CN102861161A Method for preparing traditional Chinese medicine wet tissue for treating scale keratosis type tinea manus and tinea pedis |
| 01/09/2013 | CN102861157A Traditional Chinese medicine mixture for treating qi and blood stasis type postpartum fever |
| 01/09/2013 | CN102861152A Chinese medicine compound or composition of its extract and application thereof |
| 01/09/2013 | CN102861133A Method for extracting kavalactones by using subcritical water |
| 01/09/2013 | CN102861128A Application of effective site of salvianolic acids to preparation of preparations for treating skin diseases |
| 01/09/2013 | CN102861116A Method for preparing pericarpium granati polyphenol gel for treating gynecological inflammation |
| 01/09/2013 | CN102861111A Medicament for preventing and treating hepatitis A, hepatitis B and hepatitis C |
| 01/09/2013 | CN102861102A Nanosilver bacteriostatic spray |
| 01/09/2013 | CN102861100A Compound injection for treating animal respiratory tracts and preparation method thereof |
| 01/09/2013 | CN102861087A Application of Houttuynoid D in anti-human fungi medicine |
| 01/09/2013 | CN102861083A Application of Houttuynoid B in anti-human fungi medicine |
| 01/09/2013 | CN102861076A Application of Houttuynoid A in antibacterial medicine |
| 01/09/2013 | CN102861067A Application of Houttuynoid E in anti-helicobacter pylori (Hp) medicine |
| 01/09/2013 | CN102861055A Application of Houttuynoid A in helicobacter pylori resisting medicine |